Ignite Creation Date:
2025-12-24 @ 12:19 PM
Ignite Modification Date:
2025-12-27 @ 10:37 PM
Study NCT ID:
NCT02098161
Status:
COMPLETED
Last Update Posted:
2023-06-06
First Post:
2014-03-21
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
LCL161 in Treating Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocytosis Myelofibrosis
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-12-18
Start Date Type:
ACTUAL
Primary Completion Date:
2022-05-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-05-19
Completion Date Type:
ACTUAL
First Submit Date:
2014-03-21
First Submit QC Date:
None
Study First Post Date:
2014-03-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2023-05-09
Results First Submit QC Date:
None
Results First Post Date:
2023-06-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-09
Last Update Post Date:
2023-06-06
Last Update Post Date Type:
ACTUAL